Market Capitalization of Genomic Valley Biotech (GVBL)
As of May 20, 2026, Genomic Valley Biotech (GVBL) market capitalisation is ₹8.11 Cr ($901,111), with 31.93 L shares outstanding at a current price of ₹25.40 on BSE, ranking 5026 out of 5362 companies by market cap in our screener. Genomic Valley Biotech operates in the Healthcare sector and is classified as a Small Cap stock. For live price, earnings and the complete company profile, see GVBL stock price BSE.
Market Cap History of Genomic Valley Biotech (Last 10 Years)
GVBL market capitalisation from year-end BSE closing prices over the last 10 years. Read Genomic Valley Biotech dividend payments for the complete payout history and dividend yield track record.
End of Year Market Cap History — Genomic Valley Biotech
GVBL year-end market cap in INR and USD with closing share price and annual change — BSE closing prices. Analyse Genomic Valley Biotech ownership pattern to track promoter, FII and institutional holdings.
| Year | Market Cap | Share Price | Exchange | Change |
|---|---|---|---|---|
| 2026 |
₹8.11 Cr
$901,111 USD
|
₹25.40 | BSE | +2.79% |
| 2025 |
₹7.89 Cr
$876,632 USD
|
₹24.71 | BSE | -69.09% |
| 2024 |
₹25.53 Cr
$2.84M USD
|
₹79.95 | BSE | +113.54% |
| 2023 |
₹11.95 Cr
$1.33M USD
|
₹37.44 | BSE | +55.68% |
| 2022 |
₹7.68 Cr
$853,217 USD
|
₹24.05 | BSE | +6.89% |
| 2021 |
₹7.18 Cr
$798,228 USD
|
₹22.50 | BSE | - |
| 2020 |
₹7.18 Cr
$798,228 USD
|
₹22.50 | BSE | - |